Live Cell Encapsulation

$PMCB Great Small BioTech Company

The Newswatch Television Official Blog

There are a handful of illnesses in this world that we are still working towards creating a cure for.

Research specialist Lia Thornberry Kent works under a fume hood dispersing a feeder solution necessary to maintain growing stem cell cultures in researcher James Thomson's lab at the University of Wisconsin-Madison. Thomson, a developmental biologist and professor of anatomy, directed the research group that reported the first isolation of embryonic stem cell lines from a nonhuman primate in 1995, work that led his group to the first successful isolation of human embryonic stem cell lines in 1998. ©UW-Madison University Communications 608/262-0067 Photo by: Jeff Miller Date:  8/05    File#:   D100 digital camera frame 10734

Nothing but time and money has gone into finding a cure for several diseases such as cancer and diabetes. Though there have been a plenty of steps in the right direction, there is still work that needs to be done in order to find a cure that will bring a complete end to these life altering illnesses. PharmaCyte Biotech is a clinical stage biotechnology company that focuses on developing treatments for both cancer and diabetes based on a revolutionary live-cell encapsulation technology known as Cell In A Box.

Cell in a Box encapsulates genetically modified cells to convert a chemotherapy drug into its cancer-killing form or to encapsulate genetically modified cells that produce insulin when a patient’s pancreas isn’t working properly. The cells that will be encapsulated in PharmaCyte Biotech’s technology…

View original post 51 more words

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s